Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
The global pandemic has presented both challenges and opportunities for the ongoing development of Cell & Gene Therapies. In the emerging world as technological progress thrives, interconnectivity between physical locations will likely remain a challenge to the supporting global supply chain.
With commercial passenger flights predominantly used by the specialist logistics sector to meet the exacting transportation needs, ongoing instability of commercial flight schedules will impact the availability of options to support time sensitive movement around the world.
Strategies that have been successful throughout the past year are likely to continue to be relevant in the post pandemic world - with trusted relationships, consistent communication and contact between stakeholders remaining vital to building and maintaining a successful supply chain.
Key takeaways from this webinar will include:
Director of Cell & Gene Therapy Logistics
Biocair
Based in Cambridge, UK, Chris has global responsibility for Cell & Gene Therapy Logistics at Biocair. Since joining Biocair in 2002 Chris has worked in a variety of roles, demonstrating Biocair’ s unique client centric approach leading teams to deliver in a wide range of challenging situations - to include the complex supply chain needs of commercial distribution for FDA approved therapies.
Supply Chain Analyst
Repertoire Immune Medicines
Vu Lam is a supply chain analyst with Repertoire Immune Medicines. With 6 years of logistics and Supply Chain experience, Vu helps to find modern solutions to today’s modern supply chain problems.
Writer
Informa Pharma Intelligence
